Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia Advocacy Hub | UniteRare

At a Glance

Live from database

Regulatory Watchboard

10 events

Oct 2026The Non-high-density Lipoprotein Cholesterol (Non-HDL-C) to High-density Lipoprotein Cholesterol (HDL-C) Ratio (NHHR) and Its Association With Occurrence of Diabetic Nephropathy in Patients With Diabetes Mellitus

Assiut University

TrialNOT YET RECRUITING

Jan 2026Axatilimab Plus Standard of Care Therapy for the Prevention of Graft Versus Host Disease Following Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Cancer, ABRAXAS Trial

Mayo Clinic — PHASE2

TrialNOT YET RECRUITING

Oct 2025Effect of Dapagliflozin on Interleukin 10 in Sepsis

Minia University

TrialNOT YET RECRUITING

Sep 2025ASTRAEA: ReinvigorAting ReSponse To ImmunotheRApy in MEtAstatic TNBC With Combination Myeloid Inhibition and Radiation

Stephen Shiao — PHASE2

TrialNOT YET RECRUITING

Jul 2025Differential Thrombogenesis by EPA and DHA Mediated by HDL

The Miriam Hospital — EARLY_PHASE1

TrialRECRUITING

Mar 2025The Effect of Propolis Administration on Cholesterol Level in Diabetic Type 2 Patients

Indonesia University — PHASE4

TrialRECRUITING

Jan 2025Association Between Uric Acid / High Density Lipoprotein Ratio and Monocyte / High Density Lipoprotein Ratio with Diabetic Complications

Assiut University

TrialNOT YET RECRUITING

Jun 2024Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes

Sohag University

TrialNOT YET RECRUITING

Dec 2023Relationship Between High-Density Lipoprotein Subtypes and Coronary Heart Disease Prognosis.

Beijing Tsinghua Chang Gung Hospital

TrialRECRUITING

Dec 2022An Intervention to Increase Genetic Testing in Families Who May Share a Gene Mutation Related to Cancer Risk and An Intervention to Help Patients and Their Primary Care Providers Stay Up-to-date About Uncertain Genetic Test Results

Memorial Sloan Kettering Cancer Center — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

Total programs

No financial assistance programs currently listed for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Check the disease page for updates →

Clinical Trial Landscape

5 active trials

1Phase 2

1N/A

3Unknown

5Total recruiting

Search clinical trials for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia →

Recent News & Research

No recent news articles indexed yet for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia.
Search PubMed for Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia →

Browse all Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia news →

Specialist Network

Top 6 by expertise

Paul Szabolcs, MD

UPMC Children's Hospital of Pittsburgh

📍 Pittsburgh, Pennsylvania

Score 297 trials

Paul Orchard, M.D., MD

Masonic Cancer Center, University of Minnesota

📍 MINNEAPOLIS, MN

Score 82 trials

Jacques Genest, MD

McGill University Health Centre/Research Institute of the McGill University Health Centre

Score 43 trials

Allan Gordon, MD, PhD

XOMA (US) LLC

Score 42 trials

Fanny MOCHEL, MCU-PH

Institut du Cerveau et de la Moëlle épinière

Score 31 trial

Marcelo J Amar, M.D., M.D

National Heart, Lung, and Blood Institute (NHLBI)

📍 BETHESDA, MD

Score 32 trials

View all Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia specialists →

Quick Actions

📄

View Disease Page

Full profile, treatments, community

🔬

Search Clinical Trials

Find recruiting studies now

🩺

Find Specialists

Ranked by expertise & trials

💰

Financial Assistance

Copay cards, PAPs, grants

📰